phase readout
saveNCT07392060: A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Shanghai Jiatan Pharmatech Co., Ltd. Phase: PHASE3. Conditions: Cervical Cancer Metastatic
view source ↗
comments(0)
5-min edit window · permanent after that